Asset Manager

Updated:

Chemed Corporation

Kevin McNamara has led Chemed since 2004, combining Roto-Rooter and VITAS Healthcare under a buyback-focused holding structure.

Chemed Corporation

Chemed Corporation was founded in 1970 as a small specialty chemical company before transforming through a series of divestitures into its current dual-subsidiary structure. Kevin McNamara joined the organization in 1991 and rose to CEO in 2004, overseeing the final exit from the chemicals business and the concentration of capital into two enduring American service platforms: VITAS Healthcare, the largest for-profit hospice provider in the United States, and Roto-Rooter, the century-old plumbing and drain service franchise. The architecture reflects a permanent-hold conviction rather than a traditional family office or serial-acquirer model. The corporation's investment posture is not that of a conventional allocator. Capital deployment is binary: internal reinvestment into the hospice and plumbing operations, and a sustained open-market share repurchase program. VITAS operates over 50 hospice programs across 14 states, generating predictable reimbursement through Medicare, while Roto-Rooter serves approximately 90% of the US population through company-owned branches and independent contractors. Unlike a diversified holding company, Chemed does not scan for third-party fund commitments or outside venture bets. Its co-investors are public shareholders; its deal flow is measured in new hospice licenses and plumbing service territories. Chemed's leadership is concentrated in Cincinnati. David Williams serves as CFO, a role he has held since 2004, providing continuous controllership through decades of the share-buyback strategy. The board includes Nicholas V. Perrino III, a former senior executive at VITAS, and Andrea R. Lindell, a former dean at the University of Cincinnati College of Nursing. The firm does not operate a philanthropic foundation at the parent level; its community footprint flows through the subsidized care provided by VITAS and the essential-service nature of Roto-Rooter. In September 2023, Chemed authorized an additional $250 million in share repurchases, continuing a buyback program that has reduced shares outstanding by over 40% since 2010 (per the firm, September 2023). The structural differentiator is the pairing of a high-reliability, death-and-taxes plumbing business with a federally regulated end-of-life care provider. This creates a corporate balance sheet that functions as a self-funding, two-asset permanent capital vehicle — one that has returned capital to shareholders almost exclusively through buybacks rather than dividends, concentrating ownership for remaining holders in a pattern distinct from both private family offices and diversified public conglomerates.

Website
chemed.com

General information

Firm type

Asset Manager

Year founded

1970

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Cincinnati

Corporate office

Cincinnati, OH, United States

Principals

Kevin J. McNamara

Chief Executive Officer

David P. Williams

Executive Vice President & Chief Financial Officer

Sector focus

Healthcare Services

Frequently asked questions

Who runs investment decisions at Chemed?

Kevin J. McNamara, CEO since 2004, directs capital allocation alongside CFO David P. Williams and the board. The firm does not employ a CIO or dedicate a team to third-party fund selection; investment decisions are operational, focused on subsidiary expansion and the share-repurchase authorization. Their tenure has been marked by sustained buybacks rather than acquisitions outside the two existing platforms.

How does Chemed source its deal flow?

Chemed does not participate in external deal flow in the traditional sense. Growth comes from opening new VITAS hospice locations and expanding Roto-Rooter territory coverage within the United States. The firm has not pursued a third-party M&A strategy or venture program; its core allocation decision is the repurchase of its own publicly traded shares.

Is Chemed a family office or an operating company?

Chemed is a publicly traded corporation that functions as a holding company for two operating subsidiaries. It does not manage personal wealth for a founding family and is not structured as a single-family office. The leadership team treats the public equity as a permanent capital vehicle, concentrating value through buybacks while maintaining operating control of VITAS and Roto-Rooter.

What investment stages and asset classes does Chemed target?

The corporation does not target external asset classes or investment stages. Its balance sheet is allocated entirely to two operating divisions — hospice care and residential plumbing services — and the company's own equity. There are no fund commitments, co-investment vehicles, or allocations to traditional alternatives on its publicly disclosed statements.

What is the relationship between VITAS Healthcare and Chemed?

VITAS Healthcare is a wholly owned subsidiary of Chemed Corporation and has been its largest revenue generator since the mid-2000s. VITAS operates as the largest for-profit hospice provider in the United States, with programs in 14 states. Chemed does not separate the subsidiary financially beyond standard segment reporting and directs VITAS cash flows into corporate-level capital decisions.

How does Chemed return capital to shareholders?

Chemed returns capital almost exclusively through open-market share repurchases rather than dividends. The board has authorized successive buyback programs, with total shares outstanding reduced by more than 40% since 2010. This approach concentrates ownership for remaining holders and reflects management's view that the stock is the highest-return use of corporate cash.

Does VITAS Healthcare accept investment from external LPs or co-investors?

No. VITAS is a fully integrated operating subsidiary of Chemed and does not syndicate individual hospice programs to outside financial partners. The only route to economic participation in VITAS is through public equity ownership of Chemed Corporation on the NYSE.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo